| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| S9083 |
Global fee urgent care centers |
26,206 |
24,651 |
$1.83M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,738 |
1,726 |
$94K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,405 |
2,315 |
$55K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
751 |
717 |
$25K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
66 |
66 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
949 |
916 |
$4K |
| 81003 |
|
3,317 |
3,242 |
$669.76 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
359 |
352 |
$203.61 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
228 |
228 |
$86.04 |
| 81025 |
|
430 |
425 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
29 |
29 |
$0.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
293 |
279 |
$0.00 |
| 86328 |
|
46 |
45 |
$0.00 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
260 |
260 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
23 |
23 |
$0.00 |
| A9150 |
Non-prescription drugs |
667 |
659 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
280 |
277 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
129 |
127 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
97 |
96 |
$0.00 |
| 82962 |
|
26 |
26 |
$0.00 |
| 87070 |
|
14 |
14 |
$0.00 |
| 93000 |
|
16 |
16 |
$0.00 |